Old mac , The HIV study is even smaller so there will be no outstanding results only a good guide just like the HCV trial .
Your test , however statistically accurate does not hide the fact that the trial was an outstanding success . No other drug has done what this has .
- Forums
- ASX - By Stock
- BIT
- hepdart paper - data analysis
BIT
biotron limited
Add to My Watchlist
0.00%
!
0.2¢

hepdart paper - data analysis, page-3
Featured News
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
|
|||||
Last
0.2¢ |
Change
0.000(0.00%) |
Mkt cap ! $2.654M |
Open | High | Low | Value | Volume |
0.0¢ | 0.0¢ | 0.0¢ | $0 | 0 |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
59 | 40200562 | 0.2¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
0.3¢ | 14112222 | 22 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
59 | 40200562 | 0.002 |
33 | 67641001 | 0.001 |
0 | 0 | 0.000 |
0 | 0 | 0.000 |
0 | 0 | 0.000 |
Price($) | Vol. | No. |
---|---|---|
0.003 | 14112222 | 22 |
0.004 | 12820969 | 17 |
0.005 | 6690600 | 5 |
0.006 | 1200000 | 2 |
0.007 | 484188 | 1 |
Last trade - 09.59am 02/07/2025 (20 minute delay) ? |
Featured News
BIT (ASX) Chart |
Day chart unavailable
The Watchlist
RC1
REDCASTLE RESOURCES LIMITED
Ron Miller, Non-Executive Director
Ron Miller
Non-Executive Director
Previous Video
Next Video
SPONSORED BY The Market Online